PRIMEGENE - Key Persons
• Responsible for the company's CMC center and formulation research center, guiding the establishment of topical formulation R&D platform.
• More than 20 years of experience in new product development and CMC team management in foreign multinational pharmaceutical companies, and experience in CMC R&D/manufacturing system leadership and management in domestic pharmaceutical companies. Experience in developing semi-solid, solid and injectable dosage forms, including special formulations, such as complex creams, nanoemulsions, nano-suspensions, oral controlled-release formulations, etc. Served as the director of API solid form strategy committee of multinational pharmaceutical companies
• Previously, he was in charge of formulation and CMC cross-disciplinary development of new products in Phase I-III clinical and commercialization phases at R&D centers of multinational pharmaceutical companies, such as Celgene, GSK, Pfizer, Eli Lilly, etc. He has been directly involved in or led the pharmacological development of several successful products.